Skip to main content
Equibles

TWO SIGMA INVESTMENTS, LP

Position in GMAB — Genmab A/S

CIK 1179392 NEW YORK, NY
Back to GMAB Full portfolio

Position in GMAB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$96,332,977
+$33,566,017 QoQ
Shares Held
3,506,843
+49.9% QoQ
Ownership
0.571%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#10
of 292 holders
Holding Since
Jun 2020
16 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in GMAB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TWO SIGMA INVESTMENTS, LP holds $7,283,390,440 across 343 Biotechnology names. GMAB ranks #22 (1.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALNY
Alnylam Pharmaceuticals, Inc.
 1,875,937 $564,713,315
2 MRNA
Moderna, Inc.
 7,193,530 $503,762,905
3 IONS
Ionis Pharmaceuticals Inc
 6,252,342 $495,748,197
4 REGN
Regeneron Pharmaceuticals, Inc.
 656,124 $409,119,558
5 BBIO
BridgeBio Pharma, Inc.
 4,722,185 $351,708,338
6 EXEL
Exelixis, Inc.
 4,209,861 $229,058,537
7 INCY
Incyte Corp
 2,003,559 $227,123,448
8 ARGX
Argenx SE
 185,638 $172,229,367

All Filings in GMAB

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $96,332,977 3,506,843
2026-03-31 $62,766,960 2,339,432
2025-12-31 $27,591,964 895,843
2025-09-30 $42,668,564 1,391,215
2025-06-30 $33,439,119 1,618,544
2025-03-31 $37,197,418 1,899,766
2024-12-31 $35,611,816 1,706,364
2024-09-30 $18,721,621 767,909
2024-06-30 $17,831,770 709,581
2024-03-31 $7,499,214 250,726
2023-06-30 $5,128,043 134,913
2022-12-31 $9,261,555 218,536
2021-03-31 $1,283,653 39,100
2020-12-31 $4,330,290 106,500
2020-09-30 $7,333,825 200,323
2020-06-30 $10,651,627 314,300